[go: up one dir, main page]

FR3123803B3 - Gas mixture usable in case of ischemic stroke - Google Patents

Gas mixture usable in case of ischemic stroke Download PDF

Info

Publication number
FR3123803B3
FR3123803B3 FR2106285A FR2106285A FR3123803B3 FR 3123803 B3 FR3123803 B3 FR 3123803B3 FR 2106285 A FR2106285 A FR 2106285A FR 2106285 A FR2106285 A FR 2106285A FR 3123803 B3 FR3123803 B3 FR 3123803B3
Authority
FR
France
Prior art keywords
ischemic stroke
case
gas mixture
mixture usable
stroke
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2106285A
Other languages
French (fr)
Other versions
FR3123803A3 (en
Inventor
Géraldine Farjot
Catherine Billoet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LAir Liquide SA pour lEtude et lExploitation des Procedes Georges Claude
Original Assignee
LAir Liquide SA pour lEtude et lExploitation des Procedes Georges Claude
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LAir Liquide SA pour lEtude et lExploitation des Procedes Georges Claude filed Critical LAir Liquide SA pour lEtude et lExploitation des Procedes Georges Claude
Priority to FR2106285A priority Critical patent/FR3123803B3/en
Publication of FR3123803A3 publication Critical patent/FR3123803A3/en
Application granted granted Critical
Publication of FR3123803B3 publication Critical patent/FR3123803B3/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0208—Oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0266—Nitrogen (N)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Titre de l’invention Mélange gazeux utilisable en cas d’accident vasculaire cérébral ischémique L’invention concerne un médicament gazeux inhalable contenant de l’argon, de l’azote et de l’oxygène gazeux, tel un mélange ternaire, pour une utilisation pour traiter, atténuer ou résorber des lésions cérébrales consécutives à un accident vasculaire cérébral ischémique (AVCi) chez un individu devant subir une thrombectomie mécanique, avec ou sans thrombolyse. Figure de l’abrégé : AucuneTitle of the invention Gaseous mixture usable in the event of ischemic stroke The invention relates to an inhalable gaseous medicament containing argon, nitrogen and oxygen gas, such as a ternary mixture, for use for treat, attenuate or resolve brain damage following an ischemic stroke (stroke) in an individual undergoing mechanical thrombectomy, with or without thrombolysis. Abstract Figure: None

FR2106285A 2021-06-15 2021-06-15 Gas mixture usable in case of ischemic stroke Active FR3123803B3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR2106285A FR3123803B3 (en) 2021-06-15 2021-06-15 Gas mixture usable in case of ischemic stroke

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2106285A FR3123803B3 (en) 2021-06-15 2021-06-15 Gas mixture usable in case of ischemic stroke
FR2106285 2021-06-15

Publications (2)

Publication Number Publication Date
FR3123803A3 FR3123803A3 (en) 2022-12-16
FR3123803B3 true FR3123803B3 (en) 2023-08-25

Family

ID=84424417

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2106285A Active FR3123803B3 (en) 2021-06-15 2021-06-15 Gas mixture usable in case of ischemic stroke

Country Status (1)

Country Link
FR (1) FR3123803B3 (en)

Also Published As

Publication number Publication date
FR3123803A3 (en) 2022-12-16

Similar Documents

Publication Publication Date Title
Rincon et al. Intracerebral hemorrhage: getting ready for effective treatments
FR3123803B3 (en) Gas mixture usable in case of ischemic stroke
DE60226881D1 (en) HIGH-DENSITY LIPOPROTEIN FOR THE TREATMENT OF IMPACT AND ISCHEMIA STATE
MA29283B1 (en) PROCESS FOR THE ENRICHMENT OF OXYGEN IN GASES, CORRESPONDING DEVICES AND THEIR USE
Stone et al. Therapies for hemorrhagic transformation in acute ischemic stroke
Ishrat et al. Vascular protection to increase the safety of tissue plasminogen activator for stroke
FR3123802B3 (en) Gas mixture based on argon and helium usable in case of ischemic stroke
Yildiz et al. Hyperbaric oxygen therapy in chronic pain management
ZA200508891B (en) Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor Xa inhibitors for the treatment of thromboses
BR0204223A (en) Low pressure carburizing process
Thangavelu Laparoscopy and anesthesia: A clinical review
NO20080890L (en) Compositions to reduce the incidence of drug-induced arrhythmia
Riha et al. Pro: methylene blue as a rescue therapy for vasoplegia after cardiac surgery
MA58653A1 (en) USE OF A GLUTARIMIDE DERIVATIVE TO TREAT DISEASES RELATED TO ABERRANT INTERLEUKIN-6 ACTIVITY
Nematihonar et al. Comparison postoperative shoulder pain, nausea, and vomiting between low and normal pressure pneumoperitoneum in laparoscopic cholecystectomy
Devuyst et al. Update on recent progress in drug treatment for acute ischemic stroke.
Campagnola The status quo between Taiwan and China: The inevitability of a dramatic end?
FR3104564B1 (en) Gas purification method and device
Schors Jewish Soldiers in Nazi Captivity: American and British Prisoners of War During the Second World War By Yorai Linenberg. Oxford: Oxford University Press, 2023. Pp. xii+ 270. Cloth $110.00. ISBN: 978-0198892786.
FR2400560A1 (en) METHOD OF MANUFACTURING A PROTECTIVE GAS FOR THE THERMAL TREATMENT OF FERROUS METALS
SU398681A1 (en) STEEL
Rind et al. Outcome of patients taking rifaxamine Vs lactose in patients with hepatic encephalopathy presenting at tertiary care hospital sukkur
Hipparagi Transgender Narratives in Postcolonial India: Intersections and Divergences A Study of Select Autobiographies.
De Waal Turkey and Armenia: A Second Chance?
Shin et al. Spinal and Epidural Anesthesia in Two Severe Hypoxemia Patients: Two case reports.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5